📰 Biodelivery Sciences News
Biodelivery Sciences News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Biodelivery Sciences. Real-time updates on events, politics, business and more.
June 10, 2024
We recently compiled the list of the 10 Stocks Receiving a Massive Vote of Approval From Wall Street Analysts. In this article, we are going to take a look at where Collegium Pharmaceutical, Inc.
April 4, 2024
JUPITER, Fla. & DURHAM - Ligand Pharmaceuticals today announced the launch of Pelthos Therapeutics , a biopharmaceutical company, and the appointment of seasoned industry executive Scott Plesha to...
April 3, 2024
Pharmaceutical executive Scott Plesha named CEO Lead product ZELSUVMI expected to be commercially available in late 2024 ...
April 3, 2024
Ligand Pharmaceuticals (LGND) announced the launch of Pelthos Therapeutics, a biopharmaceutical company. Pelthos is a wholly owned subsidiary of Ligand. Pelthos is committed to commercializing therapeutic products to help patients impacted by diseases with limited treatment options.
April 3, 2024
(RTTNews) - Ligand Pharmaceuticals (LGND) announced the launch of Pelthos Therapeutics, a biopharmaceutical company. Pelthos is a wholly owned sub...
June 23, 2023
SAN DIEGO, June 23, 2023 /PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments to address some of the most important unmet...
June 23, 2023
/PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company focused on improving the lives of patients by developing...
April 20, 2023
Around the house: Cushman & Wakefield taps Univar for new GC, BDO promotes legal head to global GC
April 6, 2023
ALKERMES PUBLIC LIMITED COMPANY DIRECTORS REPORT AND CONSOLIDATED FINANCIAL STATEMENTS For the Financial Year Ended... | April 6, 2023
December 29, 2022
This biotech stock holds promise in the new year, whether it's bought out or not....EXEL